News from regulus therapeutics inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 07, 2014, 16:05 ET

Regulus to Present at the Wedbush Life Sciences Management Access Conference

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Aug 06, 2014, 16:05 ET

Regulus Reports Second Quarter 2014 Financial Results and Recent Highlights

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Aug 05, 2014, 08:00 ET

Regulus Enters Into New Collaboration Agreement with Biogen Idec to Identify microRNA Biomarkers in Multiple Sclerosis

 Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs,...

Jul 30, 2014, 16:05 ET

Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Jul 21, 2014, 08:00 ET

Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Jun 25, 2014, 08:00 ET

Regulus Announces Patent Grant from U.S. Patent Office in Sarnow Patent Estate on microRNA Therapeutics for the Treatment of HCV

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Jun 16, 2014, 08:00 ET
Regulus Therapeutics Inc. Appoints Paul C. Grint, M.D. as Chief Medical Officer (PRNewsFoto/Regulus Therapeutics Inc.)

Regulus Appoints Paul C. Grint, M.D. as Chief Medical Officer

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

May 09, 2014, 16:05 ET

Regulus to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

May 08, 2014, 16:05 ET

Regulus Reports First Quarter 2014 Financial Results and Recent Highlights

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

May 01, 2014, 16:05 ET

Regulus Announces Timing for First Quarter 2014 Financial Results Webcast and Conference Call

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Apr 30, 2014, 16:05 ET

Regulus to Present at the Deutsche Bank 39th Annual Healthcare Conference

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Apr 07, 2014, 08:00 ET

Regulus Presents Positive Preclinical Data on miR-21 and miR-221 Oncology Programs In Oral and Poster Presentations at AACR 2014 Annual Meeting

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Apr 04, 2014, 16:05 ET

Regulus to Present at the 13th Annual Needham Healthcare Conference

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Mar 25, 2014, 08:00 ET

Regulus and Alport Syndrome Foundation Raise Awareness of Life-Threatening, Genetic Kidney Disease

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Mar 05, 2014, 08:00 ET

Regulus Commences Dosing RG-101 in Healthy Volunteers in Phase I Study

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Feb 27, 2014, 16:05 ET

Regulus Provides Strategic Update and Reports Fourth Quarter and Year-End 2013 Financial Results and Recent Highlights

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Feb 26, 2014, 16:05 ET

Regulus to Present at Cowen and Company 34th Annual Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Feb 20, 2014, 16:05 ET

Regulus Announces Timing for Fourth Quarter and Year-End 2013 Financial Results Webcast and Conference Call

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Feb 19, 2014, 08:00 ET

Regulus Advances Orphan Disease Portfolio with Nomination of RG-012 as Clinical Development Candidate for the Treatment of Alport Syndrome

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Feb 13, 2014, 08:00 ET

Regulus Appoints Head of Regulus microMarkers™ R&D Division

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...